Victoria Socha

DocwireNews

There are few data available on the epidemiology of acute kidney injury (AKI), associated risk factors, treatment, and mortality among pediatric patients with <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/covid-19-update-fda-authorizes-pfizers-covid-19-for-people-ages-12-to-15-and-more/">COVID-19</a> admitted to the intensive care unit (ICU). AKI is recognized as a severe complication among children and adolescents with COVID-19. Rupesh Raina, MD, and colleagues conducted a comprehensive literature search to identify published literature related to AKI in <a href="https://link.springer.com/article/10.1007%2Fs00467-021-05084-x">pediatric COVID-19</a> patients, including incidence and outcomes.The researchers searched PubMed, MEDLINE, and Cochrane Center Trials and identified 24 studies that reported outcomes of interest. Across all 24 studies, there were 1247 children who tested positive for COVID-19. Median age of the population was 9.1 years. AKI incidence was 30.51%; only 0.56% required kidney replacement therapy. The mortality rate was 2.55%, and the incidence of multisystem inflammatory syndrome was 74.29%.&ldquo;AKI has shown to be a negative prognostic factor in adult patients with COVID-19 and now also in the pediatric cohort with high incidence and mortality rates,&rdquo; the researchers said. &ldquo;Additionally, our findings show a strong comparison in epidemiology between adult and pediatric COVID-19 patients; however, they need to be confirmed with additional data and studies.&rdquo;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Incidence and Outcomes of AKI in Pediatric Patients with COVID-19

Acute Kidney Injury

There are few data available on the epidemiology of acute kidney injury (AKI), associated risk factors, treatment, and mortality among pediatric patients with COVID-19 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe